Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients

Published:2020-09-17 Issue:6 Volume:11 Page:1501-1508
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:Journal of Cachexia, Sarcopenia and Muscle

Author:

Le‐Rademacher Jennifer¹,Lopez Camden²,Wolfe Eric¹,Foster Nathan R.¹,Mandrekar Sumithra J.¹,Wang Xiaofei³,Kumar Rajiv⁴,Adjei Alex⁵,Jatoi Aminah⁵^ORCID

Affiliation:

1. Department of Health Sciences Research Mayo Clinic Rochester MN USA

2. Alzheimer's Therapeutic Research Institute San Diego CA USA

3. Department of Biostatistics and Bioinformatics Duke University Durham NC USA

4. Division of Nephrology Mayo Clinic Rochester MN USA

5. Department of Oncology Mayo Clinic Rochester MN USA

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12625

Reference18 articles.

1. What are the criteria for response to cachexia treatment?

2. Endpoints in clinical trials in cancer cachexia: where to start?

3. Request for regulatory guidance for cancer cachexia intervention trials

4. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

5. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “It gave me a sense of achievement and a sense of purpose”—a qualitative study of patient experiences of a virtually supervised exercise program for adults with advanced cancer and cachexia;Supportive Care in Cancer;2024-05

2. The relationship between weight gain during chemotherapy and outcomes in patients with advanced non‐small cell lung cancer;Journal of Cachexia, Sarcopenia and Muscle;2024-03-11

3. High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study;Nutrients;2023-12-07

4. Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle;BJC Reports;2023-08-02

5. Development and applicability of modified weight loss grading system in cancer: a real‐world cohort study;Journal of Cachexia, Sarcopenia and Muscle;2023-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3